… In the midst of the current COVID-19 pandemic, a variety of prophylactic and therapeutic
treatments are being developed or repurposed to combat COVID-19. Monoclonal antibodies (…

… A monoclonal antibody is created by exposing a white blood cell to a particular viral protein,
… produce antibodies to target that virus. Prior to COVID-19, monoclonal antibodies were …

… the need to study monoclonal antibodies in patients most likely to benefit from … monoclonal
antibody therapy. A potential limitation of monoclonal antibodies for treatment of COVID-19 is …

… Human monoclonal antibodies are safe, preventive, and … caused by the coronavirus disease
2019 (COVID-19) pandemic. … from 14 COVID-19 survivors, 453 neutralizing antibodies were …

… COVID-19 patient; or (ii) via antibodies that are biotechnologically designed, ie, therapeutic
monoclonal antibodies (… of antibody-based prophylactic and therapeutic COVID-19 treatment. …

… monoclonal antibodies serve as an antiviral agent to reduce the viral load in the nasopharynx.
The effects of monoclonal antibodies … of agents to treat early Covid-19. In the trial by Chen …

… intense development as treatments for COVID-19. In addition to … COVID-19. Herein, we
highlight some key points regarding mAb-based detection tests and treatments for the COVID-19 …

… virus to severe acute respiratory syndrome coronavirus (SARS-CoV) … of specific monoclonal
antibodies against to COVID-19 (B38, H4, … the potential of monoclonal antibody therapy as a …

… COVID-19 disease and its complications, especially in the elderly individuals. More than 50
monoclonal antibody-… trials of different monoclonal antibodies used to treat COVID-19, with …

… However, none of them have been approved for COVID-19 yet. … for the treatment and
prophylaxis of COVID-19. Currently, several … will be critical for the control of COVID-19 pandemic. …